Skip to main content

UPDATE 1-Novartis confirms 2018 targets as Alcon recovery gains steam

* Cosentyx sales miss analysts' forecast (Adds comment from CEO, details about drugs.)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.